These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6295272)

  • 1. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 7. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
    Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
    Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.
    Crumpacker CS; Schnipper LE; Marlowe SI; Kowalsky PN; Hershey BJ; Levin MJ
    N Engl J Med; 1982 Feb; 306(6):343-6. PubMed ID: 6275267
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
    Park NH; Pavan-Langston D; Declercq E
    Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    Levin MJ; Weinberg A; Leary JJ; Sarisky RT
    Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS.
    Gateley A; Gander RM; Johnson PC; Kit S; Otsuka H; Kohl S
    J Infect Dis; 1990 Apr; 161(4):711-5. PubMed ID: 2156946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child.
    Sibrack CD; Gutman LT; Wilfert CM; McLaren C; St Clair MH; Keller PM; Barry DW
    J Infect Dis; 1982 Nov; 146(5):673-82. PubMed ID: 6290575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.
    Wade JC; McLaren C; Meyers JD
    J Infect Dis; 1983 Dec; 148(6):1077-82. PubMed ID: 6317768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
    Sibrack CD; McLaren C; Barry DW
    Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of acyclovir-resistant and -sensitive clinical herpes simplex virus isolates from an immunocompromised patient.
    Christophers J; Sutton RN
    J Antimicrob Chemother; 1987 Sep; 20(3):389-98. PubMed ID: 2824424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
    L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
    Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.